Prudence Lam
Impact in
-
- Peptidase Inhibition and Analysis
- Global Cancer Incidence and Screening
- Cancer Risks and Factors
-
- Toxin Mechanisms and Immunotoxins
- Galectins and Cancer Biology
Papers in
- Oncology 7
- Cancer Risks and Factors 4
- Inflammatory Biomarkers in Disease Prognosis 2
- Peptidase Inhibition and Analysis 2
-
- Lymphoma Diagnosis and Treatment 2
- Co-authors
- Berta M. Geller (1 shared paper)Pamela M. Vacek (1 shared paper)Gerburg M. Wulf (2 shared papers)Kun Ping Lu (2 shared papers)Erin Hofstatter (1 shared paper)Laura N. Burga (1 shared paper)Xiao Zhen Zhou (1 shared paper)Greg Finn (1 shared paper)
- Journals
- Journal of Clinical Oncology (2 papers)Molecular Cancer (1 paper)JCO Global Oncology (1 paper)Clinical Lung Cancer (1 paper)Cancer (1 paper)
- Partner nations
- United StatesIndiaUnited Kingdom
In The Last Decade
Prudence Lam
14 papers receiving 232 citations
Peers
Comparison fields: 5 of 42
- Oncology 108
- Immunology 43
- Pulmonary and Respiratory Medicine 61
- Cancer Research 27
- Hematology 20
Countries citing papers authored by Prudence Lam
This map shows the geographic impact of Prudence Lam's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Prudence Lam with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Prudence Lam more than expected).
Fields of papers citing papers by Prudence Lam
This network shows the impact of papers produced by Prudence Lam. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Prudence Lam. The network helps show where Prudence Lam may publish in the future.
Co-authors
The 25 scholars most cited alongside Prudence Lam, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2000 | 88 | |
| 2 | 2008 | 62 | |
| 3 | 2006 | 45 | |
| 4 | 2023 | 25 | |
| 5 | 2023 | 7 | |
| 6 | 2020 | 3 | |
| 7 | 2022 | 3 | |
| 8 | 2006 | 2 | |
| 9 | 2024 | 2 | |
| 10 | 2021 | 1 | |
| 11 | 2023 | 1 | |
| 12 | 2022 | 1 | |
| 13 | 2021 | 1 | |
| 14 | 2021 | 1 |
About Prudence Lam
Prudence Lam is a scholar working on Oncology, Pathology and Forensic Medicine, Hematology, Cancer Research and Molecular Biology, having authored 14 papers that have together received 242 indexed citations. Recurring topics across this work include Cancer Risks and Factors (4 papers), Inflammatory Biomarkers in Disease Prognosis (2 papers), BRCA gene mutations in cancer (2 papers), Lymphoma Diagnosis and Treatment (2 papers), Peptidase Inhibition and Analysis (2 papers), Signaling Pathways in Disease (2 papers), Cancer, Lipids, and Metabolism (2 papers) and Acute Myeloid Leukemia Research (1 paper). The work is most often cited by research in Oncology (108 citations), Immunology (43 citations), Pulmonary and Respiratory Medicine (61 citations), Cancer Research (27 citations) and Hematology (20 citations). Prudence Lam has collaborated with scholars based in United States, India and United Kingdom. Frequent co-authors include Berta M. Geller, Pamela M. Vacek, Gerburg M. Wulf, Kun Ping Lu, Erin Hofstatter, Laura N. Burga, Xiao Zhen Zhou, Greg Finn, Futoshi Suizu and Chinmay Jani. Their work appears in journals such as Journal of Clinical Oncology, Molecular Cancer, JCO Global Oncology, Clinical Lung Cancer and Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.